Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Pfizer (Spain)
h-index: 70
Total citations: 20,775
Total papers: 1,014
Homepage:
https://www.pfizer.com/
Recent papers from Pfizer (Spain)
Outcomes by Body Mass Index in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Treated with Inotuzumab Ozogamicin
Targeted Oncology · 2026
Clinical management of adverse events in patients with advanced HER2+ metastatic breast cancer treated with tucatinib, trastuzumab, and capecitabine
The Oncologist · 2026
Broadening the Assessment of Antimicrobial Value: Insights from Two Evaluations of Aztreonam–Avibactam in Spain
Infectious Diseases and Therapy · 2026
Second-line bosutinib for chronic phase chronic myeloid leukemia after imatinib: final, 10-year results of a phase I/II study
Haematologica · 2026
The Clinical and Symptomatic Burden Among Older Adults with Respiratory Syncytial Virus: A Real-World Survey in Five European Countries
Infectious Diseases and Therapy · 2026
Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: a systematic literature review of real-world evidence
The Breast · 2026
Management of bleeds in people living with hemophilia A or B without inhibitors and receiving marstacimab: A plain language summary of publication from the BASIS study
SHILAP Revista de lepidopterología · 2026
Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in Europe.
2026
Elranatamab: Mechanism of Action, Clinical, and Translational Science.
2026
Maximizing the impact of real-world evidence on cancer treatment: what do we need to achieve it?
Journal of Comparative Effectiveness Research · 2026
Treatment satisfaction, disease severity and healthcare use in patients with axial spondyloarthritis in the United States and Europe
Lara D. Veeken · 2026
Resource use and economic burden of respiratory syncytial virus among older adults in real-world clinical practice across five European countries
Frontiers in Public Health · 2026
Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.
2019
Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction
2019
Molecular evidence of field cancerization initiated by diabetes in colon cancer patients
2019
A Response to: Letter to the Editor Regarding “Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician’s Choice of Treatment in Spain”
Oncology and Therapy · 2026
Efficacy of abrocitinib and dupilumab in itch‐dominant atopic dermatitis: An analysis of 2 trials
Journal of the European Academy of Dermatology and Venereology · 2026
Abstract PS5-01-28: Us real-world clinical outcomes of tucatinib, trastuzumab, and capecitabine following trastuzumab deruxtecan for the treatment of her2+ metastatic breast cancer
Clinical Cancer Research · 2026
Abstract PS1-09-03: Let's talk about sexuality: SEXual SATisfaction questionnaire in patients with Metastatic breast cancer (SEXSAT-M)
Clinical Cancer Research · 2026
P1049Real-world effectiveness and safety of etrasimod in Ulcerative Colitis: interim analysis of the EFFECT-UC study
Journal of Crohn s and Colitis · 2026